Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1998;98:2534-2537

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roivainen, M.
Right arrow Articles by Tuomilehto, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roivainen, M.
Right arrow Articles by Tuomilehto, J.

(Circulation. 1998;98:2534-2537.)
© 1998 American Heart Association, Inc.


Clinical Investigation and Reports

Enterovirus Infections as a Possible Risk Factor for Myocardial Infarction

Merja Roivainen, PhD; Georg Alfthan, PhD; Pekka Jousilahti, MD, PhD; Marko Kimpimäki, BM; Tapani Hovi, MD, PhD; Jaakko Tuomilehto, MD, MPolSc, PhD

From the Departments of Virology (M.R., M.K., T.H.), Nutrition (G.A.), and Epidemiology and Health Promotion (P.J., J.T.), National Public Health Institute, Helsinki, Finland.

Correspondence to Prof Jaakko Tuomilehto, Department of Epidemiology and Health Promotion, National Public Health Institute, Mannerheimintie 166, FIN-00300 Helsinki, Finland. E-mail jaakko.tuomilehto{at}ktl.fi

Background—An increasing body of evidence suggests that, in addition to the well-known classic risk factors, some microbial infections may be associated with the development of atherosclerosis and myocardial infarction (MI). The aim of our study was to evaluate the possible role of enteroviral infections in the pathogenesis of MI.

Methods and Results—Stored sera, collected in Eastern Finland in 1977, from a set of 12 155 randomly selected men and women aged 25 to 64 years were used in prospective, nested case-control study. The study sample comprised 183 men and 81 women with MI and matched controls. The sera were tested for IgG antibodies to a newly identified enterovirus-common (EVC) antigen, to heat-denatured coxsackievirus B5 (CBV-5), and to adenovirus hexon protein. Raw data from enzyme immunoassays were converted to relative units before analysis. In univariate analysis, EVC antibodies were significantly associated with the risk of MI in men (P=0.009) but not in women. Men with MI had a significantly higher mean level of EVC antibodies than matched controls (P=0.014). High antibody levels to EVC were associated with an increased risk of MI in men aged 25 to 49 years (relative risk [RR] 4.34, P<0.001) but not in older men (>50 years of age). Women with MI also showed a trend toward higher antibody levels than control women, but the difference was not statistically significant. Antibody levels to whole CBV-5 or adenovirus hexon protein appeared to be no different among case patients versus control subjects.

Conclusions—If we assume that a high level of EVC antibodies reflects a history of relatively frequent enterovirus infections, the present observation might suggest that enterovirus infections increase the risk of MI at least in middle-aged men. Further studies are needed to understand possible clinical significance of this observation.


Key Words: viruses • myocardial infarction • follow-up studies




This article has been cited by other articles:


Home page
Ther Adv Cardiovasc DisHome page
E. Pesonen, M. El-Segaier, K. Persson, M. Puolakkainen, S. Sarna, H. Ohlin, and P. J. Pussinen
Infections as a stimulus for coronary occlusion, obstruction, or acute coronary syndromes
Therapeutic Advances in Cardiovascular Disease, December 1, 2009; 3(6): 447 - 454.
[Abstract] [PDF]


Home page
J. Gen. Virol.Home page
H. Al-Hello, A. Paananen, M. Eskelinen, P. Ylipaasto, T. Hovi, K. Salmela, A. N. Lukashev, S. Bobegamage, and M. Roivainen
An enterovirus strain isolated from diabetic child belongs to a genetic subcluster of echovirus 11, but is also neutralised with monotypic antisera to coxsackievirus A9
J. Gen. Virol., August 1, 2008; 89(8): 1949 - 1959.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. Andreoletti, L. Venteo, F. Douche-Aourik, F. Canas, G. L. de la Grandmaison, J. Jacques, H. Moret, N. Jovenin, J.-F. Mosnier, M. Matta, et al.
Active Coxsackieviral B Infection Is Associated With Disruption of Dystrophin in Endomyocardial Tissue of Patients Who Died Suddenly of Acute Myocardial Infarction
J. Am. Coll. Cardiol., December 4, 2007; 50(23): 2207 - 2214.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
J.-M. Fernandez-Real, A. Lopez-Bermejo, J. Vendrell, M.-J. Ferri, M. Recasens, and W. Ricart
Burden of Infection and Insulin Resistance in Healthy Middle-Aged Men
Diabetes Care, May 1, 2006; 29(5): 1058 - 1064.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. T Keller, A. T.A Mairuhu, M. D de Kruif, S. K Klein, V. E.A Gerdes, H. ten Cate, D. P.M Brandjes, M. Levi, and E. C.M van Gorp
Infections and endothelial cells
Cardiovasc Res, October 15, 2003; 60(1): 40 - 48.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
O. J de Boer, A. E Becker, and A. C van der Wal
T lymphocytes in atherogenesis--functional aspects and antigenic repertoire
Cardiovasc Res, October 15, 2003; 60(1): 78 - 86.
[Full Text] [PDF]


Home page
J. Epidemiol. Community HealthHome page
P Jousilahti, V Salomaa, V Rasi, E Vahtera, and T Palosuo
Association of markers of systemic inflammation, C reactive protein, serum amyloid A, and fibrinogen, with socioeconomic status
J Epidemiol Community Health, September 1, 2003; 57(9): 730 - 733.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Smieja, J. Gnarpe, E. Lonn, H. Gnarpe, G. Olsson, Q. Yi, V. Dzavik, M. McQueen, S. Yusuf, and for the Heart Outcomes Prevention Evaluation (HOPE
Multiple Infections and Subsequent Cardiovascular Events in the Heart Outcomes Prevention Evaluation (HOPE) Study
Circulation, January 21, 2003; 107(2): 251 - 257.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
P. J. Pussinen, T. Vilkuna-Rautiainen, G. Alfthan, K. Mattila, and S. Asikainen
Multiserotype Enzyme-Linked Immunosorbent Assay as a Diagnostic Aid for Periodontitis in Large-Scale Studies
J. Clin. Microbiol., February 1, 2002; 40(2): 512 - 518.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
J. Boman and M. R. Hammerschlag
Chlamydia pneumoniae and Atherosclerosis: Critical Assessment of Diagnostic Methods and Relevance to Treatment Studies
Clin. Microbiol. Rev., January 1, 2002; 15(1): 1 - 20.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. Basso, F. Calabrese, D. Corrado, and G. Thiene
Postmortem diagnosis in sudden cardiac death victims: macroscopic, microscopic and molecular findings
Cardiovasc Res, May 1, 2001; 50(2): 290 - 300.
[Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
S A Morre, W Stooker, W K Lagrand, A J C van den Brule, and H W M Niessen
Microorganisms in the aetiology of atherosclerosis
J. Clin. Pathol., September 1, 2000; 53(9): 647 - 654.
[Abstract] [Full Text] [PDF]


Home page
JDRHome page
K.J. Mattila, S. Asikainen, J. Wolf, H. Jousimies-Somer, V. Valtonen, and M. Nieminen
Age, Dental Infections, and Coronary Heart Disease
Journal of Dental Research, February 1, 2000; 79(2): 756 - 760.
[Abstract] [PDF]


Home page
CirculationHome page
M. Roivainen, M. Viik-Kajander, T. Palosuo, P. Toivanen, M. Leinonen, P. Saikku, L. Tenkanen, V. Manninen, T. Hovi, and M. Manttari
Infections, Inflammation, and the Risk of Coronary Heart Disease
Circulation, January 25, 2000; 101(3): 252 - 257.
[Abstract] [Full Text] [PDF]